FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jyothi Maddineni

Research Profile

Chemicals & Drugs

Concepts & Ideas

Molecular Weight

Physiology

Anatomy

Procedures

Co-author Network

Publications

TOP 3
Jeanine M Walenga; M Margaret Prechel; Walter P Jeske; Debra Hoppensteadt; Jyothi Maddineni; Omer Iqbal; Harry L Messmore; Mamdouh Bakhos
Rivaroxaban--an oral, direct Factor Xa inhibitor--has potential for the management of patients with heparin-induced thrombocytopenia.
Jyothi Maddineni; Debra A Hoppensteadt; Umberto Cornelli; Marco Manoni; Jawed Fareed
Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfate.
Jyothi Maddineni; Walter P Jeske; Francis Baltasar; Umberto Cornelli; Marco Manoni; Debra A Hoppensteadt; Jawed Fareed
Modulatory effects of Escherichia coli capsular-derived sulfaminoheparosans and heparins on tissue factor-mediated activation of platelets: flow cytometric analysis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jyothi Maddineni (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Jeanine M Walenga; M Margaret Prechel; Walter P Jeske; Debra Hoppensteadt; Jyothi Maddineni; Omer Iqbal; Harry L Messmore; Mamdouh Bakhos
Rivaroxaban--an oral, direct Factor Xa inhibitor--has potential for the management of patients with heparin-induced thrombocytopenia.
British journal of haematology 2008;143(1):92-9.
2007: Jyothi Maddineni; Debra A Hoppensteadt; Umberto Cornelli; Marco Manoni; Jawed Fareed
Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfate.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2007;13(1):52-64.
2006: Jyothi Maddineni; Walter P Jeske; Francis Baltasar; Umberto Cornelli; Marco Manoni; Debra A Hoppensteadt; Jawed Fareed
Modulatory effects of Escherichia coli capsular-derived sulfaminoheparosans and heparins on tissue factor-mediated activation of platelets: flow cytometric analysis.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2006;12(3):311-7.
2006: Jyothi Maddineni; Jeanine M Walenga; Walter P Jeske; Debra A Hoppensteadt; Jawed Fareed; Rakesh Wahi; Rodger L Bick
Product individuality of commercially available low-molecular-weight heparins and their generic versions: therapeutic implications.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2006;12(3):267-76.
2004: Michelle Florian-Kujawski; Debra Hoppensteadt; Jyothi Maddineni; H Ziegler; Jawed Fareed
Differential regulation of thrombin activatable fibrinolytic inhibitor by low molecular weight heparins. Pharmacologic implications.
International angiology : a journal of the International Union of Angiology 2004;23(4):346-54.
2004: Jawed Fareed; Qing Ma; Michelle Florian; Jyothi Maddineni; Omer Iqbal; Debra A Hoppensteadt; Rodger L Bick
Differentiation of low-molecular-weight heparins: impact on the future of the management of thrombosis.
Seminars in thrombosis and hemostasis 2004;30 Suppl 1():89-104.
2004: Jyothi Maddineni; Qing Ma; Debra A Hoppensteadt; Muzaffer Demir; Marco Manoni; Umberto Cornelli; Jawed Fareed
Molecular and pharmacologic profile of tinzaparin and a comparable low-molecular-weight bacterial sulfaminoheparosan.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2004;10(1):27-37.